Our Blog

[#pageName]

We run our blog to keep you up to date with what we are doing, our progress and our findings. If you have a subject you would like us to blog about please get in touch.

1215 including 70 international recruits (23.08.17)

  • The CaPP3 Study Day for UK site teams was held in London on 29th September 2017

    posted on Thursday, 12th October 2017

    Not tagged.

    The CaPP3 Study Day for UK site teams was held in London on 29th September 2017

    The CaPP3 study was delighted to be able to hold a study day, on 29th September, to meet with the CaPP3 study teams from around the UK.

    The meeting was held at Friends House in London; CaPP3 teams from 22 of the 26 UK sites attended. The Chief Investigator John Burn welcomed the CaPP3 personnel and gave a talk entitled 'Why repurpose aspirin?', showing the increasing weight of evidence for aspirin to be prescribed for cancer prevention, especially in high risk populations. Richard Gallon, PhD student with the CaPP3 study at Newcastle University, talked to the group about his Lynch Syndrome related research. It was also an opportunity to discuss the recent amendment to the open phase of the study and address any problems with study systems. 

  • Exeter re-consent their first recruit onto the open phase of the CaPP3 Study

    posted on Wednesday, 2nd August 2017

    Not tagged.

    Exeter re-consent their first recruit onto the open phase of the CaPP3 Study

    From left to right:  Diane Baker and Dr Carole Brewer

    Dr Carole Brewer, Consultant in Clinical Genetics at Exeter has re-consented their first recruit, Diane Baker, onto the open phase of the CaPP3 Study.  Diane is a Trustee of Lynch Syndrome UK.

Latest News

Downloads

  • Lynch Syndrome UK

    posted on Thursday, 5th March 2015

    Lynch Syndrome UK is a registered charity stemming from a long running support group on Facebook.  Our many members are passionate about our cause to educate and empower people living with this genetic condition and offering support to both them and their families when they need it most.

  • Cancer Research UK: Trials and research

    posted on Monday, 24th November 2014

    CaPP3 is now listed on the Cancer Research UK's trials and research database.